Skin Substitute Updates
Date: 10/01/21
Effective November 1, 2021, Arizona Complete Health-Complete Care Plan will update skin substitute prior authorization requirements to align with the AHCCCS preferred products. Non-preferred products will require authorization for all providers. Preferred products with their own specific code will not require an authorization for in-network providers.
As a reminder, failure to obtain prior authorization may result in claim(s) denial.
Providers are encouraged to utilize Arizona Complete Health’s online Pre-Auth Check Tool, located in the For Providers section of our website. See www.azcompletehealth.com for the latest prior authorization requirements for all procedure codes.
Please view the table on the next two pages for details on products, procedure codes, and prior auth requirements.
ADDITIONAL INFORMATION
Providers are encouraged to access Arizona Complete Health’s online secure provider portal at provider.azcompletehealth.com/ for real-time information, including eligibility verification, claims submissions/status, prior authorizations submissions/status, plan summaries, and more.
If you have questions regarding the information contained in this update or need your assigned Provider Engagement Specialist contact information, please email AzchProviderEngagement@azcompletehealth.com.
Product Name | Preferred Status | PA Required | Skin Substitute Type | Manufacturer | FDA Clearance Pathway |
ALLOPATCH PLIABLE THIN | Preferred | No PA for PAR Providers | Cellular/dermal replacement from human placental membrane | MTF Biologics | PHS Section 361 Product |
AMNIOBAND MEMBRANE | Preferred | No PA for PAR Providers | Allograft Placental Matrix - a fresh amniotic membrane aseptically | MTF Biologics | PHS Section 361 Product |
AMNIOBAND MEMBRANE PARTICULATE | Preferred | No PA for PAR Providers | Allograft Placental Matrix - a fresh amniotic membrane aseptically | MTF Biologics | PHS Section 361 Product |
AMNIOEXCEL / AMNIOEXCEL PLUS | Preferred | No PA for PAR Providers | Acellular Dermal- dehydrated human amnion-derived tissue | Integra LifeScience | PHS Section 361 Product |
APPLIGRAF | Preferred | No PA for PAR Providers | Cellular/epidermal and dermal replacement from combined human and animal sources | Organogenesis | PMA Product |
CYTAL 1, 2, 3 & 6 LAYER | Preferred | No PA for PAR Providers | Acellular/Dermal replacement from animal tissue source - is comprised of porcine urinary bladder matrix | Integra LifeScience | 510(k) Product |
DERMGRAFT | Preferred | No PA for PAR Providers | Cellular/dermal replacement from combined natural and synthetic materials | Organogenesis | PMA Product |
KERECIS | Preferred | PA for all providers due to unassigned J-code | Acellular/Dermal replacement from animal tissue source - Fish dermal matrix composed of fish | KERECIS | 510(k) Product |
OMNIGRAFT | Preferred | No PA for PAR Providers | Bilayer matrix epidermal layer and collagen/chondroitin-6-sulfate matrix promoting dermal regeneration | Integra LifeScience | PMA Product |
PRIMATRIX | Preferred | No PA for PAR Providers | Acellular/Dermal replacement from animal tissue source - is derived from fetal bovine dermis. | Integra LifeScience | 510(k) Product |
PRIMATRIX AG | Preferred | No PA for PAR Providers | Acellular/Dermal replacement from animal tissue source - is derived from fetal bovine dermis. | Integra LifeScience | 510(k) Product |
PRIMATRIX AG FENESTRATED | Preferred | No PA for PAR Providers | Acellular/Dermal replacement from animal tissue source - is derived from fetal bovine dermis. | Integra LifeScience | 510(k) Product |
PRIMATRIX AG MESHED | Preferred | No PA for PAR Providers | Acellular/Dermal replacement from animal tissue source - is derived from fetal bovine dermis. | Integra LifeScience | 510(k) Product |
PRIMATRIX FENESTRATED | Preferred | No PA for PAR Providers | Acellular/Dermal replacement from animal tissue source - is derived from fetal bovine dermis. | Integra LifeScience | 510(k) Product |
PRIMATRIX MESHED | Preferred | No PA for PAR Providers | Acellular/Dermal replacement from animal tissue source - is derived from fetal bovine dermis. | Integra LifeScience | 510(k) Product |
PURAPLY XT | Preferred | No PA for PAR Providers | Porcine intestinal collagen | Organogenesis | 510(k) Product |
SOMAGEN MESHED THIN | Preferred | No PA for PAR Providers | Allograft Dermal Matrix | MTF Biologics | PHS Section 361 Product |
THERASKIN | Preferred | No PA for PAR Providers | Biologically active cryopreserved human skin allograft with both epidermis and dermis layers | Soluble Systems LLC | PHS Section 361 Product |
AFFINITY | Non-Preferred | PA for all providers | Human Amniotic Allograft | Organogenesis | PHS Section 361 Product |
EPIFIX / EPIFEX MESH | Non-Preferred | PA for all providers | Acellular Dermal -dehydrated amniotic products | MIMEDX GROUP, INC | PHS Section 361 Product |
GRAFIX PL PRIME / GRAFIX PRIME | Non-Preferred | PA for all providers | Cellular/dermal replacement from human placental membrane | SMITH+NEPHEW | PHS Section 361 Product |
LENEVA | Non-Preferred | PA for all providers | Allograft Placental Matrix | MTF Biologics | PHS Section 361 Product |
Oasis® Wound Matrix Fenestrated | Non-Preferred | PA for all providers | Porcine intestinal collagen - are naturally derived scaffolds of ECM, composed of porcine small intestinal submucosa | SMITH+NEPHEW | 510(k) Product |
EZ DERM | Non-Preferred - Pending AHCCCS review | PA for all providers | Porcine Dermis | Mölnlycke Health Care | 510(k) Product |